Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

DNA vaccines against anthrax.

Darrell R Galloway1, Les Baillie

  • 1Naval Medical Research Center, Biodefense Research Directorate, Silver Spring, MD, USA.

Expert Opinion on Biological Therapy
|October 6, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Subclinical Anthrax Exposure in Railroad Workers Following Soil Disruption in an Endemic Region: A Seroprevalence Study in Kars, Türkiye.

Pathogens (Basel, Switzerland)·2026
Same author

Application of Monoclonal Anti-Mycolate Antibodies in Serological Diagnosis of Tuberculosis.

Tropical medicine and infectious disease·2024
Same author

Soil Sample Analysis of <i>Bacillus anthracis</i> Contaminated Animal Burial Sites.

Microorganisms·2024
Same author

Rapid, Point-of-Care Microwave Lysis and Electrochemical Detection of <i>Clostridioides difficile</i> Directly from Stool Samples.

Bioengineering (Basel, Switzerland)·2024
Same author

Co-formulation of the rF1V plague vaccine with depot-formulated cytokines enhances immunogenicity and efficacy to elicit protective responses against aerosol challenge in mice.

Frontiers in immunology·2024
Same author

Human Exposure to Naturally Occurring <i>Bacillus anthracis</i> in the Kars Region of Eastern Türkiye.

Microorganisms·2024

DNA vaccination offers a simple approach for developing vaccines against biothreat agents like anthrax. Research shows promising results for DNA vaccines against anthrax, paving the way for future multi-agent vaccines.

Area of Science:

  • Immunology
  • Vaccinology
  • Biotechnology

Background:

  • Renewed interest in vaccines against anthrax and biothreat agents.
  • DNA vaccination presents a rapid and responsive development approach.
  • Anthrax serves as a model for genetic immunization technology.

Purpose of the Study:

  • To explore DNA vaccination as a method for anthrax immunization.
  • To assess the potential of DNA vaccination for biothreat agent vaccines.
  • To advance genetic immunization technologies using the anthrax model.

Main Methods:

  • Investigating DNA vaccination strategies for anthrax.
  • Evaluating the efficacy of genetic immunization against biothreats.
  • Utilizing the anthrax model for technology development.

Related Experiment Videos

Main Results:

  • DNA vaccination against anthrax shows promising results.
  • Genetic immunization technology development is advancing.
  • Potential for new multi-agent vaccine development.

Conclusions:

  • DNA vaccination is a viable and simple immunization strategy.
  • Anthrax DNA vaccines are a promising area of research.
  • The anthrax model is crucial for advancing genetic immunization.